@incollection{,
	
					
					
					41D7336918798F1F5007D5778C5E9EA4
				,
	author={{Amro A.Amara}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}22717
}

@incollection{b0,
	
	
		,
	title={{Antimycobacterium, anticancer, and antiviral properties of probiotics: An overview}}
		,
	author={{
			CAarti
		}}
	
	
		,
	booktitle={{Microbes and Infectious Diseases}}
				
			,
	year={2020}
			0
			
		
	

}

@incollection{b1,
	
	
		,
	title={{The Minimum Inhibition and Growth Concentrations for Controlling Fungal Infections as well as Ghost Cells Preparation: Aspergillus flavus as a Model}}
		,
	author={{
			AbdEl-Baky
		} and {
			N
		}}
		
	
	
		,
	journal={{Biomedical Journal}}
		
			1
			5
			,
	year={2018}
		
	

}

@incollection{b2,
	
	
		,
	title={{Protein and DNA isolation from Aspergillus niger as well as ghost cells formation}}
		,
	author={{
			AbdEl-Baky
		} and {
			N
		}}
		
	
	
		,
	journal={{SOJ Biochem}}
		
			4
			1
			
			,
	year={2018}
		
	

}

@incollection{b3,
	
	
		,
	title={{Letter: role of probiotics in the COVID-19 pandemic}}
		,
	author={{
			EJ TAguila
		}}
	
	
		,
	journal={{Alimentary Pharmacology & Therapeutics}}
		
			52
			5
			
			,
	year={2020}
		
	

}

@book{b4,
	
	
		,
	title={{Kostenlos viral ghosts, bacterial ghosts microbial ghosts and more}}
		,
	author={{
			AAAmara
		}}
		
			,
	year={2015}
			,
	publisher={Schuling Verlag -Germany}
		
	

}

@incollection{b5,
	
	
		,
	title={{Saccharomyces cerevisiae Ghosts Using the Sponge-Like Re-Reduced Protocol}}
		,
	author={{
			AAAmara
		}}
	
	
		,
	journal={{SOJ Biochemistry}}
		
			
			,
	year={2015}
		
	

}

@incollection{b6,
	
	
		,
	title={{Vaccines against Pathogens: A Review and Food For Thought}}
		,
	author={{
			AAAmara
		}}
	
	
		,
	journal={{SOJ Biochem}}
		
			2
			2
			20
			,
	year={2016}
		
	

}

@incollection{b7,
	
	
		,
	title={{Sponge-like: a new protocol for preparing bacterial ghosts}}
		,
	author={{
			AAAmara
		} and {
			MMSalem-Bekhit
		} and {
			FKAlanazi
		}}
		
		
		ID 545741
	
	
		,
	journal={{The Scientific World Journal V}}
		
			1013
			7
			,
	year={2013}
		
	

}

@incollection{b8,
	
	
		,
	title={{Plackett-Burman randomization method for bacterial ghosts preparation form E. coli JM109}}
		,
	author={{
			AAAmara
		} and {
			MMSalem-Bekhit
		} and {
			Alanazi
		} and {
			FK
		}}
		
		
		
	
	
		,
	journal={{Saudi Pharmaceutical Journal}}
		
			22
			
			,
	year={2014}
		
	

}

@incollection{b9,
	
	
		,
	title={{Evaluation the surface antigen of the Salmonella typhimurium ATCC 14028 ghosts prepared by "SLRP}}
		,
	author={{
			AA A FAmara
		}}
	
	
		,
	journal={{The Scientific World Journal}}
		
			,
	year={2014. 2014}
		
	

}

@incollection{b10,
	
	
		,
	title={{Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model}}
		,
	author={{
			IAzagra-Boronat
		}}
	
	
		,
	journal={{Nutrients}}
		
			12
			2
			498
			,
	year={2020}
		
	

}

@book{b11,
	
	
		,
	title={{Novel Insights into the Role of Probiotics in Respiratory Infections, Allergies, Cancer, and Neurological Abnormalities}}
		,
	author={{
			IBalta
		}}
		
			,
	year={2021}
			9
			60
		
	

}

@incollection{b12,
	
	
		,
	title={{Monograph Rinderpest and peste des petits ruminants: virus plagues of large and small ruminants}}
		,
	author={{
			TBarrett
		}}
	
	
		,
	journal={{Series: Biology of Animal Infections}}
		,
	editor={P.-P. Pastoret,}
		
			,
	year={2005}
			,
	publisher={Academic Press}
		
	
	,
	note={series editor)}

}

@incollection{b13,
	
	
		,
	title={{Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic}}
		,
	author={{
			DBaud
		}}
	
	
		,
	journal={{Frontiers in Public Health}}
		
			8
			,
	year={2020}
		
	

}

@incollection{b14,
	
	
		,
	title={{Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity}}
		,
	author={{
			DBento
		}}
	
	
		,
	journal={{European Journal of Pharmaceutics and Biopharmaceutics}}
		
			93
			
			,
	year={2015}
		
	

}

@incollection{b15,
	
	
		,
	title={{Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19}}
		,
	author={{
			DBlanco-Melo
		}}
	
	
		,
	journal={{Cell}}
		
			181
			5
			
			,
	year={2020. e1039}
		
	

}

@incollection{b16,
	
	
		,
	title={{SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block}}
		,
	author={{
			JMBurke
		}}
	
	
		,
	journal={{RNA}}
		
			27
			11
			
			,
	year={2021}
		
	

}

@incollection{b17,
	
	
		,
	title={{Coronaviruses: General Features}}
		,
	author={{
			DCavanagh
		} and {
			PBritton
		}}
		
	
	
		,
	booktitle={{Encyclopedia of Virology}}
				,
	editor={
			BW JMahy
			MH VVan-Regenmortel
		}
		USA
		
			,
	publisher={Elsevier Inc}
			,
	year={2008}
			
		
	
	,
	note={Third edition}

}

@incollection{b18,
	
	
		,
	title={{SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-? Production}}
		,
	author={{
			KChen
		}}
	
	
		,
	journal={{Viruses}}
		
			13
			1
			47
			,
	year={2020}
		
	

}

@incollection{b19,
	
	
		,
	title={{Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study}}
		,
	author={{
			NChen
		}}
	
	
		,
	journal={{The Lancet}}
		
			395
			
			,
	year={2020. 10223}
		
	

}

@incollection{b20,
	
	
		,
	title={{Gastrointestinal Involvement in SARS-CoV-2 Infection}}
		,
	author={{
			THChen
		}}
	
	
		,
	journal={{Viruses}}
		
			14
			6
			,
	year={2022}
		
	

}

@incollection{b21,
	
	
		,
	title={{COVID-19 Vaccine Frontrunners and Their Nanotechnology Design}}
		,
	author={{
			YHChung
		}}
	
	
		,
	journal={{ACS Nano}}
		
			14
			10
			
			,
	year={2020}
		
	

}

@incollection{b22,
	
	
		,
	title={{Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19}}
		,
	author={{
			GEttorre
		}}
	
	
		,
	journal={{Frontiers in Medicine}}
		
			7
			,
	year={2020}
		
	

}

@incollection{b23,
	
	
		,
	title={{Antimicrobial substances from lactic acid bacteria for use as food preservatives}}
		,
	author={{
			MADaeschel
		}}
	
	
		,
	journal={{Food Technol}}
		
			43
			1
			164
			,
	year={1989}
		
	

}

@incollection{b24,
	
	
		,
	title={{Innate immunity: the first line of defense against SARS-CoV-2}}
		,
	author={{
			MSDiamond
		} and {
			T.-DKanneganti
		}}
		
	
	
		,
	journal={{Nature Immunology}}
		
			23
			
			,
	year={2022}
		
	

}

@incollection{b25,
	
	
		,
	title={{Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2}}
		,
	author={{
			JEEbinger
		}}
	
	
		,
	journal={{Nature Medicine}}
		
			27
			6
			
			,
	year={2021}
		
	

}

@incollection{b26,
	
	
		,
	title={{Depending on Epitope Profile of COVID-19 mRNA Vaccine Recipients: Are They More Efficient Against the Arising Viral Variants? An Opinion Article}}
		,
	author={{
			NEl-Baky
		} and {
			AAAmara
		}}
		
	
	
		,
	journal={{Frontiers in Medicine}}
		
			9
			903876
			,
	year={2022}
		
	

}

@incollection{b27,
	
	
		,
	title={{Newcastle disease virus (LaSota strain) as a model for virus Ghosts preparation using H2O2 bio-critical concentration}}
		,
	author={{
			NAEl-Baky
		} and {
			AAAmara
		}}
		
	
	
		,
	journal={{International Science and Investigation Journal}}
		
			3
			
			,
	year={2014}
		
	

}

@incollection{b28,
	
	
		,
	title={{Influenza A (H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells}}
		,
	author={{
			CFage
		}}
	
	
		,
	journal={{Viruses}}
		
			14
			2
			,
	year={2022}
		
	

}

@incollection{b29,
	
	
		,
	title={{Effect on immunity to challenge and antibody response of variation in dosage schedule of rabies vaccine in mice}}
		,
	author={{
			KHabel
		}}
	
	
		,
	journal={{Bull World Health Organ}}
		
			14
			4
			
			,
	year={1956}
		
	

}

@book{b30,
	
	
		,
	title={{SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways}}
		,
	author={{
			LHan
		}}
		
			,
	year={2020}
		
		
			Cold Spring Harbor Laboratory
		
	

}

@incollection{b31,
	
	
		,
	title={{Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion}}
		,
	author={{
			AHossain
		}}
	
	
		,
	journal={{Microb Pathog}}
		
			170
			105699
			,
	year={2022}
		
	

}

@incollection{b32,
	
	
		,
	title={{Characteristics of SARS-CoV-2 and COVID-19}}
		,
	author={{
			BHu
		}}
	
	
		,
	journal={{Nature Reviews Microbiology}}
		
			19
			3
			
			,
	year={2020}
		
	

}

@incollection{b33,
	
	
		,
	title={{Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China}}
		,
	author={{
			CHuang
		}}
	
	
		,
	journal={{The Lancet}}
		
			395
			
			,
	year={2020. 10223}
		
	

}

@incollection{b34,
	
	
		,
	title={{Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen}}
		,
	author={{
			MJiang
		}}
	
	
		,
	journal={{Frontiers in Immunology}}
		
			12
			,
	year={2021}
		
	

}

@incollection{b35,
	
	
		,
	title={{An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations}}
		,
	author={{
			BKantarcioglu
		}}
	
	
		,
	journal={{Clinical and Applied Thrombosis}}
		
			28
			107602962110566
			,
	year={2022}
		
	
	,
	note={Hemostasis}

}

@book{b36,
	
	
		,
	title={{Respiration, human., Encyclopaedia Britannica Student and Home Edition. Chicago: Encyclopaedia Britannica}}
		,
	author={{
			RAKlocke
		}}
		
			,
	year={2013}
		
	

}

@incollection{b37,
	
	
		,
	title={{SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant}}
		,
	author={{
			YKonno
		}}
	
	
		,
	journal={{Cell reports}}
		
			32
			12
			
			,
	year={2020}
		
	

}

@incollection{b38,
	
	
		,
	title={{Genetic Variants of SARS-CoV-2-What Do They Mean?}}
		,
	author={{
			ASLauring
		} and {
			EBHodcroft
		}}
		
	
	
		,
	journal={{JAMA}}
		
			325
			
			,
	year={2021}
		
	

}

@incollection{b39,
	
	
		,
	title={{Addition of probiotics to antibiotics improves the clinical course of pneumonia in young people without comorbidities: A randomized controlled trial}}
		,
	author={{
			CHLee
		}}
	
	
		,
	journal={{Sci. Rep}}
		
			11
			926
			,
	year={2021}
		
	

}

@incollection{b40,
	
	
		,
	title={{Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages}}
		,
	author={{
			PLee
		}}
	
	
		,
	journal={{Immune Network}}
		
			21
			1
			,
	year={2021}
		
	

}

@incollection{b41,
	
	
		,
	title={{The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway}}
		,
	author={{
			J.-YLi
		}}
	
	
		,
	journal={{Virus research}}
		
			286
			
			,
	year={2020}
		
	

}

@incollection{b42,
	
	
		,
	title={{A brief history of vaccines and vaccination}}
		,
	author={{
			MLombard
		}}
	
	
		,
	journal={{Revue Scientifique et Technique de l'OIE}}
		
			26
			1
			
			,
	year={2007}
		
	

}

@incollection{b43,
	
	
		,
	title={{Probiotic Effects against Virus Infections: New Weapons for an Old War}}
		,
	author={{
			ALopez-Santamarina
		}}
	
	
		,
	journal={{Foods}}
		
			10
			1
			130
			,
	year={2021}
		
	

}

@incollection{b44,
	
	
		,
	title={{SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion}}
		,
	author={{
			ZYLow
		}}
	
	
		,
	journal={{Viruses}}
		
			14
			9
			,
	year={2022}
		
	

}

@incollection{b45,
	
	
		,
	title={{From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease}}
		,
	author={{
			AMortellaro
		} and {
			PRicciardi-Castagnoli
		}}
		
	
	
		,
	journal={{Immunology &amp}}
		
			89
			3
			
			,
	year={2011}
		
	
	,
	note={Cell Biology}

}

@book{b46,
	
	
		,
	title={{Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination}}
		,
	author={{
			LMüller
		}}
		
			,
	year={2021}
		
		
			Cold Spring Harbor Laboratory
		
	

}

@incollection{b47,
	
	
		,
	title={{Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults}}
		,
	author={{
			MJMulligan
		}}
	
	
		,
	journal={{Nature}}
		
			586
			7830
			
			,
	year={2020}
		
	

}

@incollection{b48,
	
	
		,
	title={{Veterinary vaccines for animal and public health}}
		,
	author={{
			PPPastoret
		} and {
			PJones
		}}
		
	
	
		,
	booktitle={{Control of infectious animal diseases by vaccination}}
				,
	editor={
			ASchudel
			& MLombard
		}
		Buenos Aires, Argentina
		
			,
	year={2004. April}
			119
			
		
	
	,
	note={Proc. OIE Conference}

}

@incollection{b49,
	
	
		,
	title={{US Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Epsilon Variant: Highly Transmissible but with an Adjusted Muted Host T-Cell Response}}
		,
	author={{
			JTPlummer
		}}
	
	
		,
	journal={{Clin Infect Dis}}
		
	

}

@incollection{b50,
	
	
		,
	title={{A Review of the Progress and Challenges of Developing a Vaccine for COVID-19}}
		,
	author={{
			OSharma
		}}
	
	
		,
	journal={{Frontiers in Immunology}}
		
			11
			,
	year={2020}
		
	

}

@incollection{b51,
	
	
		,
	title={{Evolutionary trajectory of SARS-CoV-2 and emerging variants}}
		,
	author={{
			JSingh
		}}
	
	
		,
	journal={{Virology Journal}}
		
			18
			1
			,
	year={2021}
		
	

}

@incollection{b52,
	
	
		,
	title={{SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production through Ubiquitin-Mediated Degradation of TBK1}}
		,
	author={{
			LSui
		}}
	
	
		,
	journal={{Frontiers in Immunology}}
		
			12
			
			,
	year={2021}
		
	

}

@incollection{b53,
	
	
		,
	title={{Antimicrobial Activity -The Most Important Property of Probiotic and Starter Lactic Acid Bacteria}}
		,
	author={{
			JSuskovich
		}}
	
	
		,
	journal={{Food Technol. Biotechnol}}
		
			48
			3
			
			,
	year={2010}
		
	

}

@incollection{b54,
	
	
		,
	title={{Coronavirus biology and replication: implications for SARS-CoV-2}}
		,
	author={{
			PV'kovski
		}}
	
	
		,
	journal={{Nature Reviews Microbiology}}
		
			19
			3
			
			,
	year={2020}
		
	

}

@book{b55,
	
	
		,
	title={{Safety and Immunogenicity of Two RNA-Based Covid-19}}
		,
	author={{
			EEWalsh
		}}
		
			,
	year={2020}
		
	

}

@incollection{b56,
	
	
		,
	title={{Vaccine Candidates}}
	
	
		,
	journal={{New England Journal of Medicine}}
		
			383
			25
			
		
	

}

@book{b57,
	
	
		,
	title={{COVID-19 vaccine tracker and landscape}}
		
		
			,
	year={2021. August 2021}
			20
		
	

}

@incollection{b58,
	
	
		,
	title={{SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2}}
		,
	author={{
			LWu
		}}
	
	
		,
	journal={{Signal Transduct. Target. Ther}}
		
			7
			8
			,
	year={2022}
		
	

}

@incollection{b59,
	
	
		,
	title={{Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China}}
		,
	author={{
			ZWu
		} and {
			JMMcgoogan
		}}
		
	
	
		,
	journal={{JAMA}}
		
			323
			13
			1239
			,
	year={2020}
		
	

}

@incollection{b60,
	
	
		,
	title={{A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity}}
		,
	author={{
			JYang
		}}
	
	
		,
	journal={{Nature}}
		
			586
			7830
			
			,
	year={2020}
		
	

}

@incollection{b61,
	
	
		,
	title={{A pneumonia outbreak associated with a new coronavirus of probable bat origin}}
		,
	author={{
			PZhou
		}}
	
	
		,
	journal={{Nature}}
		
			579
			7798
			
			,
	year={2020}
		
	

}